Evidence map›Paper›PMID 29752618›Full record

ArticlePurinergic signalling2018

Tritium-labeled agonists as tools for studying adenosine A

Sonja Hinz, Wessam M Alnouri, Ulrich Pleiss, Christa E Müller

Abstract read
In one paragraph

Article in Purinergic signalling, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Structure and function of adenosine receptor heteromers.Cellular and molecular life sciences : CMLS · 2021
    Review
  4. Review
  5. Chemical Probes for the Adenosine Receptors.Pharmaceuticals (Basel, Switzerland) · 2019
    Review
  6. AInternational journal of molecular sciences · 2019
    Review
  7. Pyrazolo[4,3-MedChemComm · 2019
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sonja HinzPharmaCenter Bonn, Pharmaceutical Institute, Pharmaceutical Chemistry I, An der Immenburg 4, 53121, Bonn, Germany.
Wessam M AlnouriPharmaCenter Bonn, Pharmaceutical Institute, Pharmaceutical Chemistry I, An der Immenburg 4, 53121, Bonn, Germany.
Ulrich PleissBayer Pharma AG, Friedrich-Ebert-Straße 217-333, 42117, Wuppertal, Germany.
Christa E MüllerPharmaCenter Bonn, Pharmaceutical Institute, Pharmaceutical Chemistry I, An der Immenburg 4, 53121, Bonn, Germany. christa.mueller@uni-bonn.de.
Bayer (Germany) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A selective agonist radioligand for A

Indexed as

Adenosine A2 Receptor AgonistsAdenosine-5'-(N-ethylcarboxamide)AminopyridinesAnimalsCHO CellsCricetinaeCricetulusHumansMiceProtein ConformationRadioligand AssayRatsReceptor, Adenosine A2BTritiumAdenosine-5'-(N-ethylcarboxamide)Adenosine A2 Receptor AgonistsAminopyridinesBAY 60-6583Receptor, Adenosine A2BTritium[3H]BAY 60-6583[3H]NECAAdenosine A2B receptorAgonist radioligandKineticsRadioligand binding

Identifiers

PMID29752618
PMCPMC6107469
OpenAlexW2801805397

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.